Dr. Boudadi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5255 Loughboro Road Northwest
Washington, DC 20016Phone+1 202-660-6500Fax+1 202-660-6501
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2014 - 2017
- University of MichiganResidency, Internal Medicine, 2010 - 2013
- University of Rochester School of Medicine and DentistryClass of 2010
- Cornell UniversityB.A., Biological Sciences, Distinction in all subjects, 2002 - 2006
Certifications & Licensure
- DC State Medical License 2017 - 2026
- MD State Medical License 2014 - 2026
- VA State Medical License 2022 - 2026
- NC State Medical License 2020 - 2022
- MI State Medical License 2010 - 2017
Publications & Presentations
PubMed
- 1 citationsProspective phase II trial of preoperative hypofractionated proton therapy for extremity and truncal soft tissue sarcoma: the PRONTO study rationale and design.Emile Gogineni, Hao Chen, Chen Hu, Karim Boudadi, Jessica Engle
Radiation Oncology. 2024-05-14 - 8 citationsAnti-PD-1 elicits regression of undifferentiated pleomorphic sarcomas with UV-mutation signaturesLaurene S. Cheung, Lingling Chen, Teniola Oke, Thomas B. Schaffer, Karim Boudadi
Journal for Immunotherapy of Cancer. 2021-06-01 - 39 citationsNivolumab plus ipilimumab, with or without enzalutamide, in AR-V7-expressing metastatic castration-resistant prostate cancer: A phase-2 nonrandomized clinical trialEugene Shenderov, Karim Boudadi, Wei Fu, Hao Wang, Rana Sullivan
The Prostate. 2021-02-26
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: